Viewing Study NCT00787969


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-25 @ 8:16 PM
Study NCT ID: NCT00787969
Status: COMPLETED
Last Update Posted: 2018-01-09
First Post: 2008-11-07
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module